Breter H, Erdmann B
Max-Delbrück-Centrum für Molekulare Medizin, Berlin-Buch, Germany.
Cell Tissue Res. 1994 Sep;277(3):457-64. doi: 10.1007/BF00300218.
Mammary-derived growth inhibitor (MDGI) has previously been localized in the mammary parenchyma, dependent on the stage of differentiation of the mammary gland. Here, we have elucidated the distribution of MDGI in the mammary stroma by a combined immunohisto- and cytochemical analysis with antibodies raised against MDGI. Distinct staining of capillary endothelial cells has been revealed. Although its subcellular distribution resembles former observations in secretory epithelial cells, the expression of MDGI in capillary endothelial cells clearly precedes that in secretory epithelial cells. On the other hand, no endothelial MDGI staining has been detected in bovine heart, which contains a fatty acid-binding protein almost identical to MDGI. The localization of MDGI in the mammary capillary endothelium is discussed in terms of its possible involvement in the intracellular transport of hydrophobic ligands or in the regulation of endothelial cell proliferation.
乳腺衍生生长抑制剂(MDGI)先前已定位在乳腺实质中,这取决于乳腺的分化阶段。在此,我们通过使用针对MDGI产生的抗体进行免疫组织化学和细胞化学联合分析,阐明了MDGI在乳腺基质中的分布。已发现毛细血管内皮细胞有明显染色。尽管其亚细胞分布类似于先前在分泌性上皮细胞中的观察结果,但MDGI在毛细血管内皮细胞中的表达明显早于分泌性上皮细胞。另一方面,在含有与MDGI几乎相同的脂肪酸结合蛋白的牛心脏中未检测到内皮MDGI染色。根据MDGI可能参与疏水性配体的细胞内运输或内皮细胞增殖的调节,讨论了MDGI在乳腺毛细血管内皮中的定位。